Latest Breaking News On - Arcuti zoryve - Page 1 : comparemela.com

Incyte crosses $1B in quarterly revenue for the 1st time, even as Jakafi faces off against GSK rival

Incyte crosses $1B in quarterly revenue for the 1st time, even as Jakafi faces off against GSK rival
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Opzelura incyteSteven steinArcuti zoryveChristiana stamoulisLuke mielsWilliam blairDermavant vtamaWall streetNorth americaBarry flannellyInflation reduction act

Arcutis treatment gets additional FDA approval | Pacific Coast Business Times

Westlake Village-based Arcutis Biotherapeutics announced that its main treatment option, Zoryve, received approval from the U.S. Drug and Food Administration for treating a skin condition called seborrheic dermatitis, the company announced on Dec. 15 It is the second FDA approval received by Arcutis’ Zoryve, being approved to be used in individuals nine years of age

Seamus fernandezArcutis biotherapeuticsFrank watanabeArcuti zoryveFood administrationJorge mercado fridayHealth care amp life scienceLatest newsSubscriber contentTop storiesTop storyTri county economy